Avoiding Pitfalls in Molecular Genetic Testing

Michael Joseph Kluk,Yu An,Philip James,David Coulter,David Harris,Bai-Lin Wu,Yiping Shen

DOI: https://doi.org/10.1016/j.jmoldx.2011.01.008

2011-01-01

Abstract:The molecular testing options available for the diagnosis of genetic disorders are numerous and include a variety of different assay platforms. The consultative input of molecular pathologists and cytogeneticists, working closely with the ordering clinicians, is often important for definitive diagnosis. Herein, we describe two patients who had long histories of unexplained signs and symptoms with a high clinical suspicion of an underlying genetic etiology. Initial molecular testing in both cases was negative, but the application of high-resolution array comparative genomic hybridization technology lead to definitive diagnosis in both cases. We summarize the clinical findings and molecular testing in each case, discuss the differential diagnoses, and review the clinical and pathological findings of Mowat-Wilson syndrome. This report highlights the importance for those involved in molecular testing to know the nature of the underlying genetic abnormalities associated with the suspected diagnosis, to recognize the limitations of each testing platform, and to persistently pursue repeat testing using high-resolution technologies when indicated. This concept is applicable to both germline and somatic molecular genetic testing. (J Mol Diagn 2011, 13:363-367; DOI:10.1016/j.jmoldx.2011.01.008)